• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ATX
Click for more information
7.69% 6.0¢

AMPLIA THERAPEUTICS LIMITED

Market Cap $11.64M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Amplia Therapeutics Limited is an Australia-based clinical-stage, drug development... Amplia Therapeutics Limited is an Australia-based clinical-stage, drug development company. The Company is focused on developing proprietary, orally available, small molecule Focal Adhesion Kinase (FAK) inhibitors as candidate drugs for the treatment of cancer and various fibrotic diseases. The Company’s pipeline includes AMP945 and AMP886. AMP945 is a selective and potent inhibitor of FAK and is in clinical development for pancreatic cancer and advanced preclinical development for idiopathic pulmonary fibrosis (IPF). The Company’s second pipeline drug, AMP886, inhibits FAK and inhibits two key disease drug targets (VEGFR3 and FLT3). This drug is being evaluated in preclinical models of cancer. Its fibrosis program uses its FAK inhibitors to block fibrosis and cell migration in cancers. Its cancer Program is directed at using its FAK inhibitors to block FAK activity in the cancer cells and the surrounding tissue and therefore block survival/proliferation signals.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
ATX
Unfair treatment to Non Aus shareholders 		01:09 0 87
01:09 Last post  Finman618 Comments Created with Sketch.  0  Views Created with Sketch.  87 
ATX
Ann: Update on ACCENT Trial in Pancreatic Cancer 		23/04/24 44 9.6K
23/04/24 Last post  petesherl Comments Created with Sketch.  44  Views Created with Sketch.  9.6K 
ATX
Ann: Trading Halt 		22/04/24 21 5.4K
22/04/24 Last post  leveller Comments Created with Sketch.  21  Views Created with Sketch.  5.4K 
ATX
News: ATX Amplia Therapeutics Says Fully Underwritten 2 For 5 Entitlement Offer 		16/04/24 0 152
16/04/24 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  152 
ATX
Ann: Proposed issue of securities - ATX 		16/04/24 0 154
16/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  154 
ATX
Ann: Entitlement Offer Cleansing Statement 		16/04/24 0 141
16/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  141 
ATX
Ann: Rights Issue Investor Slide Deck 		16/04/24 0 240
16/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  240 
ATX
Ann: Fully Underwritten 2 for 5 Entitlement Offer to raise $4.27 		16/04/24 0 227
16/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  227 

See All Discussions arrow Created with Sketch.

Timeline

Proposed issue of securities - ATX
16 Apr 10:08
 
Entitlement Offer Cleansing Statement
16 Apr 10:08
 
Rights Issue Investor Slide Deck
16 Apr 10:08
 
Fully Underwritten 2 for 5 Entitlement Offer to raise $4.27
16 Apr 10:07
 
Trading Halt
12 Apr 09:47
 
AACR Conference Presentation
10 Apr 08:22
 
View More arrow Created with Sketch.

Featured News

AUQ Alara forced to push back copper concentrate production
right-arrow Created with Sketch.
RCE Recce weighs in on Q1 2024 as cash increases 100%
right-arrow Created with Sketch.
NEWS Are there gains to be made with the grocery giants?
right-arrow Created with Sketch.
NEWS Brent Crude and gold surge as Israel attacks Iran
right-arrow Created with Sketch.
NEWS Week 16 wrap: VIX jumps; IMF eyes US debt; Oz CPI & Mag7 reports next week
right-arrow Created with Sketch.
NEWS Australia continues to beef up domestic crit mineral supply chains
right-arrow Created with Sketch.

Latest Videos

Amplia Therapeutics mints $2.4m R&D tax benefit


20 Oct 2023 10:46 (AEDT)

(20min delay)
Last
6.0¢ 		Change
-0.005(7.69%) 		Mkt cap ! $11.64M
Open High Low Value Volume
6.2¢ 6.4¢ 6.0¢ $11.58K 191.3K

Buyers (Bids)

No. Vol. Price($)
1 21070 5.8¢
 

Sellers (Offers)

Price($) Vol. No.
6.0¢ 8130 1
View Market Depth
Last trade - 16.10pm 23/04/2024 (20 minute delay) ?
Last
6.1¢ 		  Change
-0.005 ( 0.00 %)
Open High Low Volume
6.1¢ 6.1¢ 6.1¢ 25205
Last updated 15.51pm 23/04/2024 ?
ATX (ASX) Chart

Top Stories

Are there gains to be made with the grocery giants?

There is a growing storm of controversy around Coles (ASX:COL) and Woolworths (ASX:WOW) as they face intense scrutiny over price hikes and supplier pressures in a Senate inquiry. This raises an interesting question as to whether investors should cut ties with these corporate giants or wheth...
Regal copper grades at Gascoyne play see shares jump 33% for Augustus Augustus Minerals is reporting high grade copper rock chip results at Ti-Tree in WA based on recent fieldwork.
AML3D secures Australian defence government contract AML3D signed a contract with the Australian Government Defence Science and Technology Group (DSTG) to supply components for marine defence
Tamboran steps on the gas to supply the Top End Tamboran Resources has taken a significant step towards commercialising the gas resources of the Betaloo Sub Basin by signing a gas supply agreement with the Northern Territory Government.
PharmAust CEO's sayanora triggers stock plunge Clinical-stage biotechnology company, PharmAust shares plunged 24 per cent so this morning, following the resignation of its CEO, Dr. Michael Thurn.

Featured News

NEWS Australia continues to beef up domestic crit mineral supply chains
right-arrow Created with Sketch.
AUQ Alara forced to push back copper concentrate production
right-arrow Created with Sketch.
NEWS Brent Crude and gold surge as Israel attacks Iran
right-arrow Created with Sketch.
NEWS Week 16 wrap: VIX jumps; IMF eyes US debt; Oz CPI & Mag7 reports next week
right-arrow Created with Sketch.
NEWS Join our Daily Newsletter to gain exclusive insights into HotCopper!
right-arrow Created with Sketch.
NEWS Are there gains to be made with the grocery giants?
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.